A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells
Conferences
Butterfield, G; Rohm, D; Roberts, A; Nethery, M; Rizzo, A; Barrangou, R; Gersbach, C
Published in: MOLECULAR THERAPY
April 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 2022
Volume
30
Issue
4
Start / End Page
271 / 272
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Butterfield, G., Rohm, D., Roberts, A., Nethery, M., Rizzo, A., Barrangou, R., & Gersbach, C. (2022). A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells. In MOLECULAR THERAPY (Vol. 30, pp. 271–272).
Butterfield, Gabriel, Dahlia Rohm, Avery Roberts, Matthew Nethery, Anthony Rizzo, Rodolphe Barrangou, and Charles Gersbach. “A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells.” In MOLECULAR THERAPY, 30:271–72, 2022.
Butterfield G, Rohm D, Roberts A, Nethery M, Rizzo A, Barrangou R, et al. A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells. In: MOLECULAR THERAPY. 2022. p. 271–2.
Butterfield, Gabriel, et al. “A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells.” MOLECULAR THERAPY, vol. 30, no. 4, 2022, pp. 271–72.
Butterfield G, Rohm D, Roberts A, Nethery M, Rizzo A, Barrangou R, Gersbach C. A Novel Cas9 System with Robust Genome and Epigenome Editing in Human Cells. MOLECULAR THERAPY. 2022. p. 271–272.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 2022
Volume
30
Issue
4
Start / End Page
271 / 272
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics